Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia

This publication has 31 references indexed in Scilit:

• Lipid-Lowering Drugs
  Drugs, 1987
• Functional Activities of Hepatic Lipoprotein Receptors
  Annual Review of Physiology, 1986
• Treatment of Hypercholesterolemia
  Annual Review of Medicine, 1986
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984
• Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.
  Journal of Clinical Investigation, 1983
• SUPERIORITY OF PARTIAL ILEAL BYPASS OVER CHOLESTYRAMINE IN REDUCING CHOLESTEROL IN FAMILIAL HYPERCHOLESTEROLAEMIA
  The Lancet, 1981
• Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial Hypercholesterolemia
  New England Journal of Medicine, 1981
• COLESTIPOL PLUS NICOTINIC ACID IN TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA
  The Lancet, 1981
• Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug Regimen
  New England Journal of Medicine, 1981
• Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activity
  FEBS Letters, 1976